Background Fungating wounds arise from primary, secondary or recurrent malignant
disease and are associated with advanced cancer. A small proportion of patients may …

Advanced breast cancer is characterized by many physical manifestations with the potential
to undermine the quality of life (most related to the cancer and some to treatments), as well …

Background Most surgical wounds heal by primary intention, that is to say, the edges of the
wound are brought together with sutures, staples, adhesive glue or clips. However, some …

lo s.‐f., hayter m., hu w.‐y., tai c.‐y., hsu m.‐y. & li y.‐f.(2012) Symptom burden and quality of
life in patients with malignant fungating wounds. Journal of Advanced Nursing68 (6), 1312 …

Malignant wounds (MWs) occur in 5–10% of all cancer patients. Malodor and exudation are
the most common side effects. The aim was to determine the influence of honey‐coated …

PURPOSE: To enhance the clinician's competence in providing local wound care for
malignant and palliative wounds. TARGET AUDIENCE: This continuing education activity is …

Malignant fungating wounds present in 5–14% of advanced cancer patients in the United
States and are a result of cancerous cells infiltrating and proliferating in the skin …

Introduction: Malignant fungating wounds (MFWs), non-healing wounds caused by
aggressive proliferation of malignant tumors, afflict 5%–14.5% of patients with advanced …

Malignant wounds occur infrequently, but are typically described as devastating and
overwhelming. However, there has been little formalised research, and the vast majority of …

Purpose Neoplastic wounds may develop as a result of primary tumor growth in the skin,
due to metastasis, or due to skin invasion by tumors emerging from deeper levels. Malignant …